SNAP25 and early-onset autosomal dominant Alzheimer disease: These results are consistent with previous studies of SNAP-25 in Alzheimer’s disease using different immunoassays[5, 6, 8, 23, 24] and demonstrated that the method was sufficiently sensitive to detect pathological changes in brain tissue samples from individual patients.